IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Total Debt (2023 - 2025)

Updated

IRulya Therapeutics' Total Debt was $18.03 million in Q4 2025, up 2.9% from the prior quarter.

Analysis

IRulya Therapeutics (IRLA) Total Debt (2023 - 2025) Analysis & Trends

From Q4 2023 onward, IRulya Therapeutics has reported Total Debt for 8 quarters.

  • In earlier years, Total Debt was $13.43 million in FY2023.
  • The Q4 2025 figure marks the highest quarterly Total Debt in data going back to Q4 2023.
  • Per Business Quant data, IRLA's Total Debt in the three quarters before Q4 2025 was $17.52 million (Q3 2025), $16.99 million (Q2 2025) and $15.27 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 44.65 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 80.90 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -11.96 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 26.23 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 62.67 Bn
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 18.03 Mn
Sep 30, 2025 17.52 Mn
Jun 30, 2025 16.99 Mn
Mar 31, 2025 15.27 Mn
Dec 31, 2024 14.32 Mn
Sep 30, 2024 14.90 Mn
Jun 30, 2024 13.83 Mn
Mar 31, 2024 13.52 Mn
Dec 31, 2023 13.43 Mn
API Access

IRulya Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=IRLA&period=max&api_key=YOUR_API_KEY